These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 731426)

  • 1. Developments of computer-based estimation of pA2 values and associated analysis.
    Stone M; Angus JA
    J Pharmacol Exp Ther; 1978 Dec; 207(3):705-18. PubMed ID: 731426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonist inhibition curves and the measurement of dissociation constants.
    Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
    Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clark plot: a semi-historical case study.
    Stone M
    J Pharm Pharmacol; 1980 Feb; 32(2):81-6. PubMed ID: 6103047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.
    Pöch G; Brunner F; Kühberger E
    Br J Pharmacol; 1992 Jul; 106(3):710-6. PubMed ID: 1504755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxazone treatment in the guinea pig ileum in vitro reveals second functional opioid receptor site.
    James MK; Leighton HJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):138-44. PubMed ID: 3027301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of drug-receptor affinity measures in the differentiation of receptors.
    Tallarida RJ
    Fed Proc; 1982 May; 41(7):2323-7. PubMed ID: 6122613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the use of a dynamic approach to the estimation of dissociation constants for reversible competitive antagonists.
    Amidon GL; Buckner CK
    J Pharmacol Exp Ther; 1981 Feb; 216(2):352-6. PubMed ID: 6257889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design of pharmacological experiments using unbiased models of agonist-antagonist interaction.
    Vere DW
    J Pharmacol Exp Ther; 1978 Jun; 205(3):617-23. PubMed ID: 660533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
    Kenakin TP
    Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for estimation of agonist dissociation constants (KA): directly fitting the postinactivation concentration-response curve to a nested hyperbolic equation.
    James MK; Morgan PH; Leighton HJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):61-9. PubMed ID: 2540322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of robust calibration to radioimmunoassay.
    Tiede JJ; Pagano M
    Biometrics; 1979 Sep; 35(3):567-74. PubMed ID: 497342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the statistics of drug-receptor constants for partial agonists.
    Marano M; Kaumann AJ
    J Pharmacol Exp Ther; 1976 Sep; 198(3):518-25. PubMed ID: 978455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
    Pennefather P; Quastel DM
    Mol Pharmacol; 1982 Sep; 22(2):369-80. PubMed ID: 6292695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B; Elz S; Pertz HH; Stark H; Schunack W
    Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear modeling of the effect of intravenous histamine infusion on rat gastric acid secretion: a biostatistical evaluation by splitting the time-effect curves.
    Oztürk Y; Ozçelikay AT; Altan VM; Altinkurt O
    Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):463-9. PubMed ID: 1784144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 'rogue' points on non-linear fitting.
    Barlow RB
    Trends Pharmacol Sci; 1993 Nov; 14(11):399-403. PubMed ID: 8296398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A modified procedure for estimating pA2--equi-concentration effect method].
    Xu DZ
    Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):568-71. PubMed ID: 2641859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response curve analysis of gastric secretory responses in the dog and man to impromidine: a new histamine-H2-receptor agonist.
    McIsaac RL; Johnston BJ; Flannery MC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):186-90. PubMed ID: 6131998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.